News
Detailed price information for Astrazeneca Plc Ord (AZNCF) from The Globe and Mail including charting and trades.
As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the ...
AstraZeneca is currently conducting a clinical study titled A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Benralizumab on ...
SIGNIFICANT EVENTS DURING 1 APRIL - 30 JUNE 2025In April, Iconovo announced an organizational change expected to reduce annual costs by approximately 14-16 MSEK starting in the third quarter of 2025.
Since AstraZeneca has quite a presence in the U.S. healthcare market and does much of its business in the country, it makes abundant sense to shift the main stock market listing and even the ...
AstraZeneca Plc’s Chief Executive Officer Pascal Soriot wants to move the drugmaker’s stock listing to the US, the Times reported, in what would be another sign of the UK’s waning status as ...
The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as many updated charts and tools.
Medical experts are dismayed over a federal report's claim that kids are overprescribed asthma medications, saying it minimizes how many lives the drugs save.
The pharmaceutical drug company AstraZeneca filed a lawsuit against the Utah attorney general claiming Utah's new law on limiting prescription drug prices goes against a federal program.
Medical experts are dismayed over a federal report’s claim that kids are overprescribed asthma medications, saying it minimizes how many lives the drugs save. Safe treatment protocols for asthma ...
Cole Schmidtknecht, 22, had insurance but couldn’t afford to refill his asthma inhaler after the cost jumped from $70 to more than $500.
Accra, May 22, GNA- The Trust Hospital has called for better access to inhale medications for asthma patients in Ghana. Dr. Juliana Oye Ameh, Chief Executive Officer of Trust Hospital, described ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results